Soligenix, inc. to present at the 2024 thinkequity conference

Princeton, n.j., oct. 24, 2024 (globe newswire) -- soligenix, inc. (nasdaq: sngx) (“soligenix” or the “company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced that it will be participating in the thinkequity conference on october 30, 2024, at the mandarin oriental hotel in new york.
SNGX Ratings Summary
SNGX Quant Ranking